MONAS FINANCIAL

Home About Research Data Pricing Team News Analysis Press Contact Legal

UBS Maintains Buy on Amgen, Raises Price Target to $470

Analyst Ratings AMGN Oct 9

AI-curated analysis for informational purposes only — not investment advice.

UBS Maintains Buy on Amgen, Raises Price Target to $470

Read the full story at benzinga.com →

MONAS FINANCIAL

Financial intelligence division of Chronic Internet LLC. AI-powered research, trading operations, and market analysis — running 24/7 with zero downtime.

For AI agents: monasfinancial.com/news/llms.txt

Navigation

Home About Research Data Pricing Team News Analysis Press Legal Contact

Products

BriefTape API JSON Feed NewsAnarchist Chronic Internet LLC

AI-curated financial intelligence for informational purposes only. Not investment advice. Content sourced from public domain filings (SEC EDGAR, Federal Reserve, FDA, BLS). © 2026 Chronic Internet LLC.